Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. | Mol Cell | 2023 | 36634675 | PubTator, text mining | PubMed |
| Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1. | Hepatol Commun | 2023 | 36633486 | PubTator, text mining | PubMed |
| Novel Insights into The Roles of N6-methyladenosine (m6A) Modification and Autophagy in Human Diseases. | Int J Biol Sci | 2023 | 36632456 | PubTator, text mining | PubMed |
| Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. | Int J Biol Sci | 2023 | 36632454 | PubTator, text mining | PubMed |
| Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification. | Theranostics | 2023 | 36632223 | PubTator, text mining | PubMed |
| ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer. | Theranostics | 2023 | 36632222 | PubTator, text mining | PubMed |
| Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure. | Int J Oral Sci | 2023 | 36631441 | PubTator, text mining | PubMed |
| Detection, regulation, and functions of RNA N6-methyladenosine modification in plants. | Plant Commun | 2023 | 36627844 | PubTator, text mining | PubMed |
| Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression. | J Exp Clin Cancer Res | 2023 | 36627634 | PubTator, text mining | PubMed |
| Epitranscriptomic N6-Methyladenosine Profile of SARS-CoV-2-Infected Human Lung Epithelial Cells. | Microbiol Spectr | 2023 | 36625663 | PubTator, text mining | PubMed |
N6-Methyladenosine and Reader Protein YTHDF2 Enhance the Innate Immune Response by Mediating DUSP1 mRNA Degradation and Activating Mitogen-Activated Protein Kinases during Bacterial and Viral Infections. | mBio | 2023 | 36625590 | PubTator, text mining | PubMed |
| Emerging Mutual Regulatory Roles between m6A Modification and microRNAs. | Int J Mol Sci | 2023 | 36614216 | PubTator, text mining | PubMed |
| ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner. | Exp Hematol Oncol | 2023 | 36609413 | PubTator, text mining | PubMed |
| METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. | Cell Stem Cell | 2023 | 36608679 | PubTator, text mining | PubMed |
| METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression. | Cancer Commun (Lond) | 2023 | 36602428 | PubTator, text mining | PubMed |
| RBP-RNA interactions in the control of autoimmunity and autoinflammation. | Cell Res | 2023 | 36599968 | PubTator, text mining | PubMed |
| METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | EMBO Rep | 2023 | 36597993 | PubTator, text mining | PubMed |
| METTL14 alleviates the development of osteoporosis in ovariectomized mice by upregulating m6A level of SIRT1 mRNA. | Bone | 2023 | 36584783 | PubTator, text mining | PubMed |
| Elucidating the Kinetic Mechanism of Human METTL16. | Biochemistry | 2023 | 36584291 | PubTator, text mining | PubMed |
| A study of RNA m6A demethylases in oral epithelial dysplasia and oral squamous cell carcinoma. | J Oral Biol Craniofac Res | 2023 | 36582218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=72